• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NSB

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD

0.00% ! 13.0¢
Market Cap $43.23M  !

NeuroScientific Biopharmaceuticals Limited is an Australia-based company, which is... NeuroScientific Biopharmaceuticals Limited is an Australia-based company, which is engaged in developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company's product portfolio includes EmtinB, a therapeutic peptide initially targeting glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn and EmtinBn). EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body's innate immune response to cell injury. Its StemSmart is a global patented technology engaged in manufacturing cell products. The use of its proprietary StemSmart technology in a special access program for fistulising Crohn’s disease.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NSB 30/01/26 1 369
30/01/26 Last post  Donnychong Comments Created with Sketch.  1  Views Created with Sketch.  369 
NSB 15/01/26 14 4.5K
15/01/26 Last post  Meme68 Comments Created with Sketch.  14  Views Created with Sketch.  4.5K 
NSB 22:46 4 1.5K
22:46 Last post  glik007 Comments Created with Sketch.  4  Views Created with Sketch.  1.5K 
NSB 21/12/25 4 2.1K
21/12/25 Last post  xerxer Comments Created with Sketch.  4  Views Created with Sketch.  2.1K 
NSB 15:26 0 330
15:26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  330 
NSB 10:20 0 321
10:20 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  321 
NSB 11/11/25 0 377
11/11/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  377 
NSB 06/11/25 0 323
06/11/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  323 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
30 Jan 08:27
 
Successful Clinical Results Achieved under Special Access
13 Jan 09:51
 
Trading Halt
09 Jan 09:27
 
Results of Annual General Meeting
12 Nov 15:06
 
Investor Webinar Update
12 Nov 10:00
 
Fourth Patient Commences StemSmart MSC Treatment
11 Nov 09:26
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
13.0¢
Change
0.000(0.00%)
Mkt cap ! $43.23M
Open High Low Volume
13.0¢ 13.0¢ 13.0¢ 32.28K

Buyers (Bids)

Vol. Price($)
80095 12.5¢
 

Sellers (Offers)

Price($) Vol.
13.5¢ 75000
Last trade - 10.10am 12/02/2026 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.